PRESS RELEASE published on 05/12/2025 at 18:00, 8 months 23 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV received transparency notifications regarding changes in shareholding percentages from Atlas Special Opportunities II, LLC. The biopharmaceutical company is focused on developing ophthalmic therapies for retinal disease Biopharmaceutical Shareholding Changes Ophthalmic Therapies Oxurion NV Transparency Notifications
PRESS RELEASE published on 05/12/2025 at 18:00, 8 months 23 days ago Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelentransacties en voldoet aan Belgische transparantiewetgeving. Het biofarmaceutisch bedrijf ontwikkelt oftalmologische therapieën Transparantiekennisgevingen Oxurion NV Oftalmologische Therapieën Belgische Transparantiewetgeving Biofarmaceutisch Bedrijf
BRIEF published on 05/09/2025 at 18:05, 8 months 26 days ago Oxurion Increases Capital Following Convertible Bond Conversion Convertible Bonds Capital Increase Atlas Special Opportunities Vision Preservation Oxurion Shares
BRIEF published on 05/09/2025 at 18:05, 8 months 26 days ago Oxurion augmente son capital suite à la conversion d'obligations convertibles Obligations Convertibles Augmentation De Capital Opportunités Spéciales Atlas Préservation De La Vision Actions Oxurion
PRESS RELEASE published on 05/09/2025 at 18:00, 8 months 26 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion, resulting in EUR 100,000 capital increase, supporting innovative therapeutics development for vision preservation in elderly. Oxurion shares update post-capital increase Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Vision Preservation
PRESS RELEASE published on 05/09/2025 at 18:00, 8 months 26 days ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC converteert 4 obligaties in Oxurion, resulterend in EUR 100.000 kapitaalverhoging. Oxurion verstrekt 1.521.372 gewone aandelen. Meer info op www.oxurion.com Kapitaalverhoging Atlas Special Opportunities Aandelen Oxurion Innovatieve Geneesmiddelen
BRIEF published on 04/25/2025 at 18:35, 9 months 9 days ago Oxurion Arrête une Transaction de 2024 et Continue les Négociations pour une Nouvelle Acquisition Acquisition Négociations CRO Oxurion Biométrie
BRIEF published on 04/25/2025 at 18:35, 9 months 9 days ago Oxurion Stops 2024 Transaction and Continues Negotiations for New Acquisition Acquisition Negotiations CRO Oxurion Biometrics
PRESS RELEASE published on 04/25/2025 at 18:30, 9 months 9 days ago Oxurion kondigt stopzetting aan van de transactie van juli 2024 en bevestigt de voortzetting van de gesprekken over het overnameproject aangekondigd in maart 2025 Oxurion NV (Euronext Brussels: OXUR) stops negotiations for majority stake acquisition in French CRO, continues talks for majority stake in CRO specializing in biometrics and advanced data management. Market updates to follow Majority Stake Acquisition Clinical Studies CRO Oxurion NV Biometrics
PRESS RELEASE published on 04/25/2025 at 18:30, 9 months 9 days ago Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025 Oxurion NV halts acquisition of French CRO, pursues deal with biometrics CRO to expand capabilities in clinical data management. Progress updates to follow Acquisition CRO Oxurion NV Clinical Data Management Biometrics
Published on 02/05/2026 at 01:35, 3 hours 23 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 4 hours 58 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 6 hours 33 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 12 hours 43 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 20:54, 8 hours 4 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 8 hours 22 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 8 hours 57 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 10 hours 3 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 10 hours 17 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 10 hours 54 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 10 hours 54 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 11 hours 13 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 11 hours 13 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL